tradingkey.logo

Pharmaceuticals

LIST1043
1929.566USD
+48.573+2.58%
Close 02/06, 16:00ETQuotes delayed by 15 min
3.85TMarket Cap
401.15MVolume
1880.993Open
1931.697High
401.15MVolume
153Up
24Down
12Unchanged
3.85TMarket Cap
1880.993Prev. Close
1880.993Low
18.40BTurnover

Pharmaceuticals

1929.566
+48.573+2.58%

Related Stocks

No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
Roivant Sciences Ltd
Roivant Sciences Ltd
ROIV
25.820
+4.680
+22.14%
7.91
24.05M
437.05M
17.81B
689.70M
9.35
4.40
23.910
8.730
0.00
0.00
+19.43%
+14.35%
+18.55%
+21.97%
+117.89%
+137.10%
+18.99%
Hyperion Defi Ord Shs
Hyperion Defi Ord Shs
HYPD
4.140
+0.680
+19.65%
--
956.28K
2.78M
29.65M
7.16M
29.93
1.69
17.180
0.850
0.00
0.00
+17.61%
+36.18%
+20.00%
-28.87%
-42.50%
+130.00%
+16.29%
Opus Genetics Inc
Opus Genetics Inc
IRD
3.010
+0.430
+16.67%
7.11
2.88M
6.76M
194.28M
64.54M
17.05
2.66
3.050
0.650
0.00
0.00
+30.30%
+17.58%
+50.50%
+52.79%
+150.83%
+161.74%
+49.75%
4
Zhengye Biotechnology Holding Ltd
Zhengye Biotechnology Holding Ltd
ZYBT
0.840
+0.119
+15.87%
--
17.65K
13.37K
39.83M
47.39M
16.00
1.41
14.300
0.720
0.00
0.00
-14.09%
-19.40%
-26.28%
-59.40%
-88.81%
-80.04%
-26.92%
5
Incannex Healthcare Inc
Incannex Healthcare Inc
IXHL
0.288
+0.038
+15.20%
4.25
8.61M
1.74M
100.14M
347.71M
17.67
1.08
2.240
0.080
0.00
0.00
-6.98%
-16.30%
-27.64%
-20.49%
-24.23%
-86.29%
-19.55%
6
Alpha Cognition Inc
Alpha Cognition Inc
ACOG
5.100
+0.600
+13.33%
6.23
28.73K
111.37K
82.88M
16.25M
13.33
0.44
11.540
3.750
0.00
0.00
+5.37%
-14.29%
-22.26%
-18.53%
-36.25%
-11.61%
-21.54%
7
Jaguar Health Inc
Jaguar Health Inc
JAGX
0.670
+0.078
+13.12%
5.78
523.00K
245.74K
2.47M
3.69M
15.19
1.20
25.750
0.560
0.00
0.00
-0.68%
-12.41%
-37.96%
-60.12%
-68.10%
-96.85%
-28.05%
8
Scisparc Ltd
Scisparc Ltd
SPRC
0.684
+0.072
+11.75%
2.43
100.37K
35.89K
365.67K
534.61K
11.94
0.34
12.138
0.584
0.00
0.00
-11.05%
-32.28%
-54.70%
-75.40%
-84.83%
-93.43%
-49.71%
9
Fortress Biotech Inc
Fortress Biotech Inc
FBIO
3.270
+0.340
+11.60%
6.61
627.39K
1.47M
101.39M
31.01M
9.21
1.03
4.530
1.325
0.00
0.00
+5.48%
-3.82%
-25.34%
+26.25%
+54.25%
+83.19%
-10.66%
10
ASP Isotopes Inc
ASP Isotopes Inc
ASPI
5.815
+0.600
+11.51%
6.92
4.61M
19.17M
542.99M
93.38M
10.73
0.72
14.490
3.650
0.00
0.00
-8.28%
-31.43%
-9.70%
-34.81%
-37.54%
-6.06%
+8.69%

News

Growth Stocks Near Their Lows: Why Figma, Zoetis, and Pinterest Look Underrated

TradingKey - Currently, if you can invest $5000 into the stock market, it is worth considering as a solid opportunity for this point in time. In addition, a number of Growth Stocks have also been underappreciated due to the audience only focusing on the top-performing companies.

TradingKeyThu, Feb 5
TradingKey - Currently, if you can invest $5000 into the stock market, it is worth considering as a solid opportunity for this point in time. In addition, a number of Growth Stocks have also been underappreciated due to the audience only focusing on the top-performing companies.

Today’s Market Recap: Chip and Software Stocks Crater as AI Conviction Wavers, AMD Plunges 17%

TradingKey - On February 4, 2026, U.S. stocks declined, weighed down by renewed pressure on technology shares. The S&P 500 slipped 0.51% to 6,882, while the Nasdaq Composite fell 1.51% to 22,905, underperforming broader benchmarks as selling concentrated in growth and semiconductor stocks.

TradingKeyThu, Feb 5
TradingKey - On February 4, 2026, U.S. stocks declined, weighed down by renewed pressure on technology shares. The S&P 500 slipped 0.51% to 6,882, while the Nasdaq Composite fell 1.51% to 22,905, underperforming broader benchmarks as selling concentrated in growth and semiconductor stocks.

What to Expect From Eli Lilly in 2026? Is LLY Stock a Good Buy Now?

The company’s main goal and focus in 2026 will be to maintain its leadership position in weight management, whilst expanding further into additional therapeutic areas, so that revenue growth will not be dependent on a singular product. It is expected that Eli Lilly’s stocks will serve as a predictor

TradingKeyWed, Feb 4
The company’s main goal and focus in 2026 will be to maintain its leadership position in weight management, whilst expanding further into additional therapeutic areas, so that revenue growth will not be dependent on a singular product. It is expected that Eli Lilly’s stocks will serve as a predictor

What Are Good Stocks to Invest in Right Now?

TradingKey - Investors like to think that timing the bottom of the stock market is extremely difficult. An expert may get it wrong – as evidenced by many recent mistakes made by professional investors.

TradingKeyWed, Feb 4
TradingKey - Investors like to think that timing the bottom of the stock market is extremely difficult. An expert may get it wrong – as evidenced by many recent mistakes made by professional investors.

Novo Nordisk 2026: Will the Ozempic Makers Benefit From the Strong Demand for Oral Wegovy?

Who owns Ozempic? Novo Nordisk (NVO) does, and that simple fact places the firm at the heart of the global discussion around GLP-1 drugs. But the story today for the market is another one.

TradingKeyWed, Feb 4
Who owns Ozempic? Novo Nordisk (NVO) does, and that simple fact places the firm at the heart of the global discussion around GLP-1 drugs. But the story today for the market is another one.

The Best Stocks to Invest in Right Now for 2026: Better Than Nvidia?

My selection of the best stocks to buy includes MercadoLibre (MELI), Amazon (AMZN), Eli Lilly (LLY), Alphabet (GOOG) (GOOGL), Vertiv (VRT), Nu Holdings (NU) and Walmart (WMT). All these companies each have a unique competitive advantage and possess the financial resilience required to survive market

TradingKeyTue, Jan 27
My selection of the best stocks to buy includes MercadoLibre (MELI), Amazon (AMZN), Eli Lilly (LLY), Alphabet (GOOG) (GOOGL), Vertiv (VRT), Nu Holdings (NU) and Walmart (WMT). All these companies each have a unique competitive advantage and possess the financial resilience required to survive market
KeyAI